Browsing: weight-loss and diet control industry
People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to…
A rare issue unites Americans across the political divide: the nation’s broken healthcare system, which is slowly killing its citizens.…
BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking to raise as much…
Exclusive: The COO of Hims & Hers was the third person to try their GLP-1 drugs—and she’s ready to share her story
Melissa Baird, a health care executive based in Seattle knows first-hand the stigma around weight at work. “I struggled with…
Elon Musk does it. His predecessor, Jack Dorsey, former CEO and cofounder of Twitter, now X, reportedly does too. Evernote’s…
Cleveland Clinic study: Sugar alcohol xylitol tied to increased risk of heart attack, stroke
Your favorite sugar-free treats may be damaging your heart health. Higher amounts of the low-calorie sweetener xylitol, often marketed as…
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
In just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to buy…
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
Patients could wean themselves off blockbuster obesity drugs such as Ozempic or Wegovy without piling the pounds back on, according…
It’s now illegal to sell weight-loss and muscle-building supplements to minors in New York, under a first-in-the-nation law that went into effect…
Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked…